CoChat

High-Glucose or -Fructose Diet Cause Changes of the Gut Microbiota and Metabolic Disorders in Mice without Body Weight Change

Open access

The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.

Abstract

High fat diet-induced changes in gut microbiota have been linked to intestinal permeability and metabolic endotoxemia, which is related to metabolic disorders. However, the influence of a high-glucose (HGD) or high-fructose (HFrD) diet on gut microbiota is largely unknown. We performed changes of gut microbiota in HGD- or HFrD-fed C57BL/6J mice by 16S rRNA analysis. Gut microbiota-derived endotoxin-induced metabolic disorders were evaluated by glucose and insulin tolerance test, gut permeability, Western blot and histological analysis. We found that the HGD and HFrD groups had comparatively higher blood glucose and endotoxin levels, fat mass, dyslipidemia, and glucose intolerance without changes in bodyweight. The HGD- and HFrD-fed mice lost gut microbial diversity, characterized by a lower proportion of Bacteroidetes and a markedly increased proportion of Proteobacteria. Moreover, the HGD and HFrD groups had increased gut permeability due to alterations to the tight junction proteins caused by gut inflammation. Hepatic inflammation and lipid accumulation were also markedly increased in the HGD and HFrD groups. High levels of glucose or fructose in the diet regulate the gut microbiota and increase intestinal permeability, which precedes the development of metabolic endotoxemia, inflammation, and lipid accumulation, ultimately leading to hepatic steatosis and normal-weight obesity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu10060761

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Metabolic disorder parameters in high-glucose diet (HGD) or high-fructose diet (HFrD) fed mice. (A) body weight changes during the 12 weeks of feeding; (B) white adipose tissue (WAT) weight; (C) fasting blood glucose; (D) serum total cholesterol; (E) serum low-density lipoprotein (LDL)-cholesterol; (F) serum endotoxin. Data are presented as the mean ± SEM for 9 mice per group (* p < 0.05, ** p < 0.01, and *** p < 0.001 vs. ND).
Figure 1 Metabolic disorder parameters in high-glucose diet (HGD) or high-fructose diet (HFrD) fed mice. (A) body weight changes during the 12 weeks of feeding; (B) white adipose tissue (WAT) weight; (C) fasting blood glucose; (D) serum total cholesterol; (E) serum low-density lipoprotein (LDL)-cholesterol; (F) serum endotoxin. Data are presented as the mean ± SEM for 9 mice per group (* p < 0.05, ** p < 0.01, and *** p < 0.001 vs. ND).CC BY · PubMed Central
Figure 2 Analysis of the gut microbial community by 16S rRNA pyrosequencing from feces of HFD, HGD and HFrD groups. (A) operational taxonomic units levels; (B) Shannon’s diversity indices; (C) principal coordinate analysis of unweighted UniFrac analysis; (D) sample clustering results based on the unweighted UniFrac analysis; (E) relative abundances plot of bacterial phyla; (F) relative abundance cladogram of bacterial taxa. Data are presented as the mean ± SEM for 3 cages per group (** p < 0.01, and *** p < 0.001 vs. ND).
Figure 2 Analysis of the gut microbial community by 16S rRNA pyrosequencing from feces of HFD, HGD and HFrD groups. (A) operational taxonomic units levels; (B) Shannon’s diversity indices; (C) principal coordinate analysis of unweighted UniFrac analysis; (D) sample clustering results based on the unweighted UniFrac analysis; (E) relative abundances plot of bacterial phyla; (F) relative abundance cladogram of bacterial taxa. Data are presented as the mean ± SEM for 3 cages per group (** p < 0.01, and *** p < 0.001 vs. ND).CC BY · PubMed Central
Figure 3 Glucose metabolism in HFD, HGD or HFrD fed mice. (A) blood glucose levels during an oral glucose tolerance tests; (B) area under the curve (AUC) of blood glucose levels; (C) blood glucose levels during an insulin tolerance tests; (D) AUC of blood glucose levels. Data are presented as the mean ± SEM for 9 mice per group (* p < 0.05, ** p < 0.01, and *** p < 0.001 vs. ND).
Figure 3 Glucose metabolism in HFD, HGD or HFrD fed mice. (A) blood glucose levels during an oral glucose tolerance tests; (B) area under the curve (AUC) of blood glucose levels; (C) blood glucose levels during an insulin tolerance tests; (D) AUC of blood glucose levels. Data are presented as the mean ± SEM for 9 mice per group (* p < 0.05, ** p < 0.01, and *** p < 0.001 vs. ND).CC BY · PubMed Central
Figure 4 HFD, HGD or HFrD-induced changes of gut permeability and related proteins expression. (A) plasma fluorescein isothiocyanate (FITC)-dextran concentration; (B) AUC of Plasma FITC-dextran levels; (C) representative images of Western blots for tight junction proteins (Occludin and ZO1) and inflammatory cytokines (IL-1β and TNF-α); (D–G) relative band intensities of Occludin (D), ZO1 (E), IL-1β (F) and TNF-α (G) normalized to those of β-actin. Data are presented as mean ± SEM for 9 mice per group (A,B) and mean percentage of ND ± SEM of three independent experiments (C-G) (* p < 0.05, ** p < 0.01, and *** p < 0.001 vs. ND).
Figure 4 HFD, HGD or HFrD-induced changes of gut permeability and related proteins expression. (A) plasma fluorescein isothiocyanate (FITC)-dextran concentration; (B) AUC of Plasma FITC-dextran levels; (C) representative images of Western blots for tight junction proteins (Occludin and ZO1) and inflammatory cytokines (IL-1β and TNF-α); (D–G) relative band intensities of Occludin (D), ZO1 (E), IL-1β (F) and TNF-α (G) normalized to those of β-actin. Data are presented as mean ± SEM for 9 mice per group (A,B) and mean percentage of ND ± SEM of three independent experiments (C-G) (* p < 0.05, ** p < 0.01, and *** p < 0.001 vs. ND).CC BY · PubMed Central
Figure 5 HFD, HGD or HFrD-induced hepatic inflammation and change of lipid metabolism. (A,B) representative images of Western blots for inflammatory cytokines (MCP1, TLR4, IL-1β and TNF-α) and lipid metabolism (FAS, CD36 and SREBP1); (C–I) relative band intensities of MCP1 (C), TLR4 (D), IL-1β (E), TNF-α (F), FAS (G), CD36 (H) and SREBP1 (I) normalized to those of β-actin. Bar values are presented as mean percentage of ND ± SEM of three independent experiments (* p < 0.05, ** p < 0.01, and *** p < 0.001 vs. ND).
Figure 5 HFD, HGD or HFrD-induced hepatic inflammation and change of lipid metabolism. (A,B) representative images of Western blots for inflammatory cytokines (MCP1, TLR4, IL-1β and TNF-α) and lipid metabolism (FAS, CD36 and SREBP1); (C–I) relative band intensities of MCP1 (C), TLR4 (D), IL-1β (E), TNF-α (F), FAS (G), CD36 (H) and SREBP1 (I) normalized to those of β-actin. Bar values are presented as mean percentage of ND ± SEM of three independent experiments (* p < 0.05, ** p < 0.01, and *** p < 0.001 vs. ND).CC BY · PubMed Central
Figure 6 HFD, HGD or HFrD-induced hepatic steatosis and adipocyte hypertrophy. (A,B) representative histological results of liver and WAT by hematoxylin and eosin staining; (C) steatosis score of liver; (D) quantification of adipocyte area. Values are expressed as means ± SEM for 3 mice per group (** p < 0.01, and *** p < 0.001 vs. ND).
Figure 6 HFD, HGD or HFrD-induced hepatic steatosis and adipocyte hypertrophy. (A,B) representative histological results of liver and WAT by hematoxylin and eosin staining; (C) steatosis score of liver; (D) quantification of adipocyte area. Values are expressed as means ± SEM for 3 mice per group (** p < 0.01, and *** p < 0.001 vs. ND).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Cited by

See all 460

Metadata

Authors
Do, M. H., Lee, E., Oh, M.-J., Kim, Y., & Park, H.-Y.
Affiliations
Korea Food Research Institute (KR)
Corresponding author
Park, Ho-Young
Venue
Nutrients
Publisher
MDPI AG
Published
2018-06-13
Volume
10
Issue
6
Pages
761
ISSN
2072-6643 (ISSN-L)
OpenAlex
W2807848689
Cited by
441
References
58
Citations by year
2026: 38 · 2025: 44 · 2024: 60 · 2023: 73 · 2022: 66 · 2021: 72 · 2020: 56 · 2019: 22 · 2018: 9
FWCI
14.14
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Ministry of Science and ICT (E0170601-02)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords
high-glucose diet, high-fructose diet, gut microbiota, metabolic endotoxemia, intestinal permeability, tight junction proteins, dyslipidemia, impaired glucose tolerance, hepatic steatosis, liver inflammation, normal weight obesity, Bacteroidetes, Proteobacteria, intestinal inflammation, C57BL/6J mice
MeSH terms
Gastrointestinal Microbiome, Dietary Sugars, Animals, Bacteria, Blood Glucose, Body Weight, Disease Models, Animal, Endotoxins, Fructose, Glucose, Inflammation, Insulin Resistance, Intestinal Mucosa, Intestines, Lipids, Male, Mice, Inbred C57BL, Permeability, Time Factors, Biomarkers, Glucose Intolerance, Adiposity, Dyslipidemias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.